KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Operating Leases (2019 - 2025)

Edwards Lifesciences has reported Operating Leases over the past 7 years, most recently at $107.1 million for Q4 2025.

  • Quarterly results put Operating Leases at $107.1 million for Q4 2025, up 35.74% from a year ago — trailing twelve months through Dec 2025 was $107.1 million (up 35.74% YoY), and the annual figure for FY2025 was $107.1 million, up 35.74%.
  • Operating Leases for Q4 2025 was $107.1 million at Edwards Lifesciences, up from $75.3 million in the prior quarter.
  • Over the last five years, Operating Leases for EW hit a ceiling of $107.1 million in Q4 2025 and a floor of $63.5 million in Q2 2022.
  • Median Operating Leases over the past 5 years was $72.1 million (2023), compared with a mean of $75.1 million.
  • Biggest five-year swings in Operating Leases: crashed 31.37% in 2023 and later soared 35.74% in 2025.
  • Edwards Lifesciences' Operating Leases stood at $94.6 million in 2021, then grew by 0.42% to $95.0 million in 2022, then crashed by 31.37% to $65.2 million in 2023, then increased by 21.01% to $78.9 million in 2024, then skyrocketed by 35.74% to $107.1 million in 2025.
  • The last three reported values for Operating Leases were $107.1 million (Q4 2025), $75.3 million (Q3 2025), and $78.7 million (Q2 2025) per Business Quant data.